Mid-Ohio Behavioral Health

Mid-Ohio Behavioral Health offers Spravato treatment in Newark for adults living with treatment-resistant depression. This FDA-approved esketamine nasal spray is given in the office, where patients are observed for two hours following each session to ensure safety.

By targeting the NMDA receptor and the glutamate system rather than serotonin, Spravato can ease depressive symptoms more quickly than conventional antidepressants. Providers use an individualized dosing schedule and evaluate progress throughout the treatment course.

The Newark office also provides TMS therapy, psychiatry, medication management, and individual, group, and family counseling. The team emphasizes a patient-centered approach that combines clinical expertise with innovative tools to help people feel well again.